Positron emission tomography (PET) represents a unique molecular tool to get in vivo
access to a wide spectrum of biological and neuropathological processes, of crucial …

Alzheimer's disease (AD) is the leading cause of dementia in the elderly. Mutations in genes
encoding proteins involved in amyloid-β peptide (Aβ) production are responsible for …

Purpose Advances in functional imaging allowed us to visualize brain glucose metabolism
in vivo and non-invasively with [18F] fluoro-2-deoxyglucose (FDG) positron emission …

Background and Objective Background and Objective: Dementia is a broad term for a
complex range of conditions that affect the brain, such as Alzheimer's disease (AD) …

Purpose An appropriate healthy control dataset is mandatory to achieve good performance
in voxel-wise analyses. We aimed at evaluating [18F] FDG PET brain datasets of healthy …

Dementia, not a particular disease but rather a gathering of conditions which ascribes the
debilitation of atleast two cerebrum capacities, cognitive decline and memory judgment has …

Purpose Given the challenges posed by the clinical diagnosis of atypical Alzheimer's
disease (AD) variants and the limited imaging evidence available in the prodromal phases …

Purpose To know whether mild cognitive impairment (MCI) patients will develop Alzheimer's
disease (AD) dementia in very short time or remain stable is of crucial importance, also …

High dietary intake of saturated fatty acids is a suspected risk factor for neurodegenerative
diseases, including Alzheimer's disease (AD). To decipher the causal link behind these …

Background: Alzheimer's disease (AD) is characterized by an involvement of brain
dopamine (DA) circuitry, the presence of which has been associated with emergence of both …